Ad Scientiam Company
Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.
Industry:
Deep Diagnostics
Technology:
Others
Estimated Revenue:
Less than $1M
Investors Number:
5
Headquarters:
Paris, Ile-de-France, France
Employee Number:
11-50
Investor Type:
For Profit
Total Funding:
$1.6M
Founded Date:
05.09.2013
Last Funding Type:
Seed